Application 209253
- Type
- ANDA
- Sponsor
- ACTAVIS LABS FL INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | AMPHETAMINE | AMPHETAMINE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | EQ 3.1MG BASE | No | No |
| 002 | AMPHETAMINE | AMPHETAMINE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | EQ 6.3MG BASE | No | No |
| 003 | AMPHETAMINE | AMPHETAMINE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | EQ 9.4MG BASE | No | No |
| 004 | AMPHETAMINE | AMPHETAMINE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | EQ 12.5MG BASE | No | No |
| 005 | AMPHETAMINE | AMPHETAMINE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | EQ 15.7MG BASE | No | No |
| 006 | AMPHETAMINE | AMPHETAMINE | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | EQ 18.8MG BASE | No | No |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 74729 | ORIG | 2023-07-13 |